Inflammatory Bowel Disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients voluntarily agree to participate in this study, demonstrate good compliance, are able to follow study requirements to complete observation and follow-up, and have signed the informed consent form; 2.Age between 18 and 65 years at the time of signing the informed consent; 3.Clinically diagnosed with autoimmune disease, or age- and sex-matched healthy volunteers;
Exclusion criteria
Exclusion criteria: 1.Patients requiring high-dose immunosuppressants or biologic rescue therapy; 2.Patients with concomitant malignant tumors or severe cardiovascular diseases, or those currently receiving other treatments that may interfere with the study results; 3.Patients unable to take dietary supplements as scheduled, or with insufficient compliance to complete follow-up and testing; 4.Any other conditions deemed inappropriate for study participation based on medical judgment;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in disease activity score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety of the intervention;Changes in immune cell function;Change in disease activity score; | — |
Countries
China
Contacts
Tianjin Union Medical Centre